Aspen Aerogels (NYSE:ASPN) Price Target Cut to $4.00 by Analysts at Barclays

Aspen Aerogels (NYSE:ASPN) had its price target reduced by Barclays from $6.00 to $4.00 in a research note released on Friday morning,Benzinga reports. Barclays currently has an underweight rating on the construction company’s stock.

ASPN has been the subject of several other research reports. Weiss Ratings reissued a “sell (d)” rating on shares of Aspen Aerogels in a research note on Wednesday, October 8th. Canaccord Genuity Group lowered their price target on shares of Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating for the company in a report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $12.67.

Aspen Aerogels Price Performance

NYSE:ASPN traded down $0.27 during trading hours on Friday, hitting $3.85. The company’s stock had a trading volume of 9,057,405 shares, compared to its average volume of 2,054,447. The stock has a fifty day simple moving average of $7.29 and a 200-day simple moving average of $6.76. The company has a market capitalization of $316.67 million, a P/E ratio of -1.01 and a beta of 2.85. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. Aspen Aerogels has a twelve month low of $3.70 and a twelve month high of $17.56.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Thursday, November 6th. The construction company reported ($0.06) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.05). The business had revenue of $73.02 million for the quarter, compared to analyst estimates of $73.42 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The firm’s revenue was down 37.8% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.17) EPS. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. On average, analysts anticipate that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Insider Activity at Aspen Aerogels

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total transaction of $32,237.10. Following the completion of the sale, the chief accounting officer directly owned 19,879 shares in the company, valued at approximately $145,315.49. This trade represents a 18.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 4.30% of the company’s stock.

Institutional Trading of Aspen Aerogels

Several hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in Aspen Aerogels by 0.5% during the third quarter. Vanguard Group Inc. now owns 4,510,370 shares of the construction company’s stock worth $31,392,000 after buying an additional 22,686 shares during the last quarter. Needham Investment Management LLC increased its position in shares of Aspen Aerogels by 14.5% during the first quarter. Needham Investment Management LLC now owns 2,737,200 shares of the construction company’s stock worth $17,491,000 after acquiring an additional 347,500 shares in the last quarter. AWM Investment Company Inc. raised its holdings in shares of Aspen Aerogels by 102.6% in the 1st quarter. AWM Investment Company Inc. now owns 2,449,221 shares of the construction company’s stock worth $15,651,000 after acquiring an additional 1,240,535 shares during the last quarter. Gagnon Securities LLC bought a new position in Aspen Aerogels in the 2nd quarter valued at about $11,243,000. Finally, Federated Hermes Inc. acquired a new position in Aspen Aerogels during the 2nd quarter valued at about $10,459,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.